Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating Activities
Net income (loss)	$ 14,736	$ (16,201)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:
Depreciation and amortization	27,198	27,023
Amortization of deferred financing costs	1,250	1,753
Credit loss expense, net	1,066	7,341
Write-downs	474	5,432
Deferred income tax benefit	(3,279)	(300)
Share-based and other non-cash compensation	12,533	13,966
Unrealized foreign currency exchange loss	175	841
Unrealized investment gains	(72)	(64)
Changes in assets and liabilities:
Accounts receivable	9,531	(14,745)
Inventories	(6,118)	(6,949)
Film assets	(9,241)	(10,420)
Deferred revenue	(3,255)	(5,291)
Changes in other operating assets and liabilities	(19,143)	(7,679)
Net cash provided by (used in) operating activities	25,855	(5,293)
Investing Activities
Purchase of property, plant and equipment	(1,009)	(2,934)
Investment in equipment for joint revenue sharing arrangements	(4,033)	(8,651)
Interest in film classified as a financial instrument		(4,731)
Acquisition of other intangible assets	(3,478)	(1,680)
Net cash used in investing activities	(8,520)	(17,996)
Financing Activities
Revolving credit facility borrowings	30,717
Repayments of revolving credit facility borrowings	(38,886)
Credit facility amendment fees paid		(2,028)
Other borrowings	315
Repurchase of common shares	(4,011)	(49,355)
Taxes withheld and paid on employee stock awards vested	(6,458)	(3,393)
Principal payment under finance lease obligations		(890)
Dividends paid to non-controlling interests	(1,438)
Net cash used in financing activities	(19,761)	(57,510)
Effects of exchange rate changes on cash	291	1,200
Decrease in cash and cash equivalents during period	(2,135)	(79,599)
Cash and cash equivalents, beginning of period	97,401	189,711
Cash and cash equivalents, end of period	$ 95,266	110,112
IMAX China
Financing Activities
Repurchase of common shares		$ (1,844)